Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Malaria
Related studies linked through entity extraction aliases.
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
- Status
- WITHDRAWN
- Phase
- N/A
A Trial on Supervised Primaquine Use in Ethiopia
- Status
- WITHDRAWN
- Phase
- PHASE4
Early Life Cohort in Papua Indonesia (ELIPI Study)
- Status
- COMPLETED
- Phase
- N/A
Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers
- Status
- COMPLETED
- Phase
- PHASE4
MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A
- Status
- COMPLETED
- Phase
- PHASE1
The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria
- Status
- COMPLETED
- Phase
- NA
Lumefantrine in Venous Plasma Versus Dried Capillary Blood Spot
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo
- Status
- COMPLETED
- Phase
- PHASE4
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)
- Status
- UNKNOWN
- Phase
- PHASE1
Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi
- Status
- UNKNOWN
- Phase
- PHASE3
Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar
- Status
- COMPLETED
- Phase
- NA
Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic
- Status
- COMPLETED
- Phase
- N/A
Sequential Optimization of Dose and Schedule of PfSPZ Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating the Role of Chloroquine for Malaria Elimination
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
- Status
- COMPLETED
- Phase
- NA
Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2